{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:43Z","timestamp":1786991143456,"version":"build-2736575974"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jaad.2016.07.060","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T08:17:11Z","timestamp":1475914631000},"page":"1198-1204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field"],"prefix":"10.1016","volume":"75","author":[{"given":"Janny E.","family":"Lommerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansje-Eva","family":"Teulings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Ezzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanja","family":"van Geel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhart","family":"Speeckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis I.","family":"Spuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wolkerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie M.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel W.","family":"Bekkenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.07.060_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2016.07.060_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.07.060_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4161\/onci.19403","article-title":"Immune mediated mechanisms of melanocyte destruction: paving the way for efficient immunotherapeutic strategies against melanoma","volume":"1","author":"Speeckaert","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaad.2016.07.060_bib4","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1610-0387.2008.06755.x","article-title":"Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features","volume":"6","author":"Hartmann","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2016.07.060_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdp325","article-title":"Vitiligo is an independent favorable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study","volume":"21","author":"Quaglino","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2016.07.060_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.07.060_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0190-9622(83)70183-0","article-title":"Malignant melanoma and vitiligo-like leukoderma: an electron microscopic study","volume":"9","author":"Koh","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.07.060_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaad.2015.05.014","article-title":"Confetti-like depigmentation: a potential sign of rapidly progressing vitiligo","volume":"73","author":"Sosa","year":"2015","journal-title":"J Am Acad Dermatology"},{"key":"10.1016\/j.jaad.2016.07.060_bib9","article-title":"Vitiligo-like depigmentations as first sign of melanoma; a retrospective case series from a tertiary vitiligo center","author":"Teulings","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.07.060_bib10","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.07.060_bib11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/pcmr.12294","article-title":"The antibody response against MART-1 differs in patients with melanoma-associated leukoderma and vitiligo","volume":"27","author":"Teulings","year":"2014","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216306144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216306144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:39:58Z","timestamp":1759271998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216306144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0190962216306144"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.07.060","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.07.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}